Journal
VIRUSES-BASEL
Volume 15, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/v15030697
Keywords
cowpea chlorotic mottle virus; purification; affinity extraction; affinity chromatography; CCMV-binding peptide; virus-like particles; plant virus; nanotechnology; nanoparticles; virus production; safety issues; ultracentrifugation-free protocol; molecular dynamics
Categories
Ask authors/readers for more resources
An advanced purification method for the plant virus CCMV was developed, involving precipitation with PEG 8000 and affinity extraction using a novel peptide aptamer. The protocol was validated using multiple methods and demonstrated exceptional purity. This improved method enables the large-scale production and application of plant viruses as nanotechnological platforms.
The cowpea chlorotic mottle virus (CCMV) is a plant virus explored as a nanotechnological platform. The robust self-assembly mechanism of its capsid protein allows for drug encapsulation and targeted delivery. Additionally, the capsid nanoparticle can be used as a programmable platform to display different molecular moieties. In view of future applications, efficient production and purification of plant viruses are key steps. In established protocols, the need for ultracentrifugation is a significant limitation due to cost, difficult scalability, and safety issues. In addition, the purity of the final virus isolate often remains unclear. Here, an advanced protocol for the purification of the CCMV from infected plant tissue was developed, focusing on efficiency, economy, and final purity. The protocol involves precipitation with PEG 8000, followed by affinity extraction using a novel peptide aptamer. The efficiency of the protocol was validated using size exclusion chromatography, MALDI-TOF mass spectrometry, reversed-phase HPLC, and sandwich immunoassay. Furthermore, it was demonstrated that the final eluate of the affinity column is of exceptional purity (98.4%) determined by HPLC and detection at 220 nm. The scale-up of our proposed method seems to be straightforward, which opens the way to the large-scale production of such nanomaterials. This highly improved protocol may facilitate the use and implementation of plant viruses as nanotechnological platforms for in vitro and in vivo applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available